Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications

Hassan, Md. I. ; Waheed, A. ; Yadav, S. ; Singh, T. P. ; Ahmad, F. (2009) Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications Cellular and Molecular Life Sciences, 66 (3). pp. 447-459. ISSN 1420-682X

Full text not available from this repository.

Official URL: http://www.springerlink.com/index/y63r212440u1075v...

Related URL: http://dx.doi.org/10.1007/s00018-008-8463-x

Abstract

Prolactin inducible protein (PIP) is a 17- kDa single polypeptide chain, known by various names due to its versatile nature and function in human reproductive and immunological systems. It is expressed in several exocrine tissues such as the lacrimal, salivary, and sweat glands. Its expression is up regulated by prolactin and androgens, and estrogens down regulate it. Due to its over-expression in metastatic breast and prostate cancer, presently PIP is considered as a prognostic biomarker. Moreover, its aspartyl-proteinase nature suggests its role in tumor progression. PIP has unique features because it is small in size and plays multiple important functions. Its ability to bind potentially with CD4-T cell receptor, immunoglobulin G (IgG), actin, zinc α2-glycoprotein (ZAG), fibronectin and enamel pellicle, reveals its important biological functions. This is the first comprehensive review on the structure and functional analysis of PIP and its clinical applications.

Item Type:Article
Source:Copyright of this article belongs to Springer.
Keywords:Prolactin Inducible Protein; Antisperm Antibody; Tumor Progression And Metastasis; Apoptosis; CD4-T Cell Receptor; Fertilization
ID Code:49138
Deposited On:19 Jul 2011 04:16
Last Modified:19 Jul 2011 04:16

Repository Staff Only: item control page